Evaxion Biotech (EVAX) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Evaxion Biotech, an AI-focused TechBio company, announced the launch of its enhanced AI-Immunology platform with an updated EDEN model to expedite the development of novel vaccines. The updated model can predict toxin antigens more accurately, which is crucial for creating effective bacterial vaccines. This advancement is set to improve the speed and efficiency of vaccine discovery, leveraging AI to meet urgent medical needs.
For further insights into EVAX stock, check out TipRanks’ Stock Analysis page.
